These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26883210)

  • 1. Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review.
    Lotfi T; Morsi RZ; Rajabbik MH; Alkhaled L; Kahale L; Nass H; Brax H; Fadlallah R; Akl EA
    BMC Health Serv Res; 2016 Feb; 16():57. PubMed ID: 26883210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review.
    Fadlallah R; Alkhaled L; Brax H; Nasser M; Rajabbik MH; Nass H; Kahale LA; Akl EA
    Eur J Public Health; 2018 Apr; 28(2):224-230. PubMed ID: 29165586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review.
    Fadlallah R; Nas H; Naamani D; El-Jardali F; Hammoura I; Al-Khaled L; Brax H; Kahale L; Akl EA
    PLoS One; 2016; 11(8):e0160540. PubMed ID: 27556929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis.
    Brax H; Fadlallah R; Al-Khaled L; Kahale LA; Nas H; El-Jardali F; Akl EA
    PLoS One; 2017; 12(4):e0175493. PubMed ID: 28406971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic review.
    Lotfi T; Morsi RZ; Zmeter N; Godah MW; Alkhaled L; Kahale LA; Nass H; Brax H; Fadlallah R; Akl EA
    BMC Res Notes; 2015 Nov; 8():720. PubMed ID: 26606971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review.
    Alkhaled L; Kahale L; Nass H; Brax H; Fadlallah R; Badr K; Akl EA
    BMJ Open; 2014 Jul; 4(7):e004880. PubMed ID: 24989618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review.
    Hassali MA; Wong ZY; Alrasheedy AA; Saleem F; Mohamad Yahaya AH; Aljadhey H
    Health Policy; 2014 Sep; 117(3):297-310. PubMed ID: 25129135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians and the pharmaceutical industry: is a gift ever just a gift?
    Wazana A
    JAMA; 2000 Jan; 283(3):373-80. PubMed ID: 10647801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' attitudes about gifts to physicians from pharmaceutical companies.
    Blake RL; Early EK
    J Am Board Fam Pract; 1995; 8(6):457-64. PubMed ID: 8585404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' attitudes towards interaction with the pharmaceutical industry.
    Alosaimi FD; Al Kaabba A; Qadi M; Albahlal A; Alabdulkarim Y; Alabduljabbar M; Alqahtani F
    East Mediterr Health J; 2015 Feb; 20(12):812-9. PubMed ID: 25664520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?
    Alssageer MA; Kowalski SR
    Pan Afr Med J; 2013; 14():132. PubMed ID: 23734277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.
    McCormick BB; Tomlinson G; Brill-Edwards P; Detsky AS
    JAMA; 2001 Oct 24-31; 286(16):1994-9. PubMed ID: 11667936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist-industry relationships.
    Saavedra K; O'Connor B; Fugh-Berman A
    Int J Pharm Pract; 2017 Dec; 25(6):401-410. PubMed ID: 28097713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pharmaceutical promotion on prescribers in Jordan.
    Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
    Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: A qualitative study.
    Hajjar R; Bassatne A; Cheaito MA; Naser El Dine R; Traboulsy S; Haddadin F; Honein-AbouHaidar G; Akl EA
    PLoS One; 2017; 12(9):e0184662. PubMed ID: 28898296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness and attitudes of the Lebanese population with regard to physician-pharmaceutical company interaction: a survey study.
    Ammous A; Bou Zein Eddine S; Dani A; Dbaibou J; El-Asmar JM; Sadder L; Akl EA
    BMJ Open; 2017 Mar; 7(3):e013041. PubMed ID: 28363922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
    Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
    Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.